Affymax Stock

Affymax Gross Margin

Gross Margin of Affymax (AFFY) as of Aug 10, 2026.

Gross Margin

0.00

Last updated:

Gross Margin of Affymax is 2026 0.00 . Gross Margin of Affymax was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Affymax Stock analysis

What does Affymax do? Affymax Inc is a leading biotechnology company specializing in the development of innovative therapeutics for patients with serious diseases. The company was founded in 2001 and is headquartered in Palo Alto, California. Affymax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Affymax stock

On Eulerpool you can find the complete historical development of Gross Margin Affymax since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Affymax with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Affymax

All Key Metrics — Affymax